In brief, what’s happening at Penn—whether it’s across campus or around the world.
A CRISPR screening tool identified a new therapeutic target to treat acute myeloid leukemia (AML) that has the potential to leave patients with fewer side effects than current approaches, according to a new study from Penn Medicine published in Molecular Cell.
FULL STORY AT Penn Medicine News →
The Scialog: Advanced Bioimaging initiative has selected the assistant professor of mechanical engineering and applied mechanics to be part of its first cohort of researchers. A combination of science and dialog, the Research Corporation for Science Advancement’s Scialog program is a series of collaboration-generating conferences and grants, focused on a range of pressing scientific issues.
FULL STORY AT Penn Engineering Today →
A new Penn Medicine study identifies a new mechanism of resistance and how to overcome it with a small molecule inhibitor.
FULL STORY AT Penn Medicine News →
Wharton’s Olivia S. Mitchell talks about the federal government’s call to reexamine its pension investments in light of climate change.
FULL STORY AT Knowledge at Wharton →
Over 30 student researchers were included in the scientific program with their faculty mentors, showcasing a diversity of projects across disciplines.
FULL STORY AT Penn Dental Medicine →
Endotracheal tubes ensure a hospital patient’s airway is clear when they can’t breathe on their own. However, keeping a foreign object inserted runs the risks of infection, inflammation, and a condition in which scar tissue narrows the airway. Broad-spectrum antibiotics are one way to mitigate these risks, but can harm beneficial bacteria and contribute to antibiotic resistance.
FULL STORY AT Penn Engineering Today →
With the delta variant driving up COVID-19 cases across the country, more companies are mandating vaccinations for employees to ward off the economic losses that come from having an unhealthy workforce. The decision by companies to require vaccines or masks doesn’t surprise Wharton management professor Iwan Barankay.
FULL STORY AT Knowledge at Wharton →
The scientists found the health of these specific cancer cells and tumors are dependent upon cholesterol and this receptor, while also showing that medication that specifically targets the receptor could make it impossible for the cancer cells to survive and spread.
FULL STORY AT Penn Medicine News →
Penn Dental Medicine faculty member Yuan Liu and postdoctoral fellow Zhi Ren have been recognized for their excellence in research, recently receiving top awards from the American Association for Dental, Oral, and Craniofacial Research (AADOCR) and the International Association for Dental Research (IADR).
FULL STORY AT Penn Dental Medicine →
It’s designed for media industry professionals, activists, community organizers, nonprofit leaders, and social entrepreneurs looking to build mission-aligned digital media strategies.
FULL STORY AT Annenberg School for Communication →
